版主:雅歌  新东  胖胖  熊熊  

头像

恭喜!这是AXON上涨的新闻见内。 (谈股论金)  385次阅读

作者: 雅歌 @, 发表于: 2018-06-07 (2157天前) @ 天涯逍遥

观看【雅歌】的博客

Shares of Axovant Sciences Ltd. (AXON) soared almost 50% in premarket trade Wednesday, after Oxford BioMedica plc said it has entered an $842.5 million licensing agreement for OXB-102, a gene therapy treatment for Parkinson's disease. Under the terms of the deal, Oxford BioMedica will receive a $30 million upfront payment, and is eligible for $55 million upon reaching certain milestones. It will receive $757.5 million on reaching regulatory and sales milestones and 7% to 10% tiered royalties on net sales of AXO-Lenti-PD. Axovant will fund all clinical development costs and expects to start a Phase 1/11 dose escalation study of AXO-Lenti-PD in patients with advanced Parkinson's by year-end. The companies will host a conference call with investors at 9.30 a.m. Eastern. Axovant shares have fallen 68.8% in 2018 so far, while the S&P 500 has gained 2.8%.


完整帖子:

 主题RSS Feed

打开手机微信,选【发现】->【扫一扫】左边的二维码就会在手机出现这个帖子,然后点击右上角的三个点,选分享到朋友圈。
我是歌手 新闻速递 谈股论金 聊天灌水 影视在线 心灵大学 原创天地 笑话连篇 美食天下 视觉艺术 伴奏交流